Literature DB >> 30390028

Integrative regulation of physiology by histone deacetylase 3.

Matthew J Emmett1,2, Mitchell A Lazar3,4.   

Abstract

Cell-type-specific gene expression is physiologically modulated by the binding of transcription factors to genomic enhancer sequences, to which chromatin modifiers such as histone deacetylases (HDACs) are recruited. Drugs that inhibit HDACs are in clinical use but lack specificity. HDAC3 is a stoichiometric component of nuclear receptor co-repressor complexes whose enzymatic activity depends on this interaction. HDAC3 is required for many aspects of mammalian development and physiology, for example, for controlling metabolism and circadian rhythms. In this Review, we discuss the mechanisms by which HDAC3 regulates cell type-specific enhancers, the structure of HDAC3 and its function as part of nuclear receptor co-repressors, its enzymatic activity and its post-translational modifications. We then discuss the plethora of tissue-specific physiological functions of HDAC3.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30390028      PMCID: PMC6347506          DOI: 10.1038/s41580-018-0076-0

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  158 in total

1.  Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.

Authors:  Simon C Biddie; Sam John; Pete J Sabo; Robert E Thurman; Thomas A Johnson; R Louis Schiltz; Tina B Miranda; Myong-Hee Sung; Saskia Trump; Stafford L Lightman; Charles Vinson; John A Stamatoyannopoulos; Gordon L Hager
Journal:  Mol Cell       Date:  2011-07-08       Impact factor: 17.970

Review 2.  Transcription factors: from enhancer binding to developmental control.

Authors:  François Spitz; Eileen E M Furlong
Journal:  Nat Rev Genet       Date:  2012-08-07       Impact factor: 53.242

3.  Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Authors:  Jason S Carroll; X Shirley Liu; Alexander S Brodsky; Wei Li; Clifford A Meyer; Anna J Szary; Jerome Eeckhoute; Wenlin Shao; Eli V Hestermann; Timothy R Geistlinger; Edward A Fox; Pamela A Silver; Myles Brown
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

4.  Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo.

Authors:  Raymond E Soccio; Eric R Chen; Satyajit R Rajapurkar; Pegah Safabakhsh; Jill M Marinis; Joanna R Dispirito; Matthew J Emmett; Erika R Briggs; Bin Fang; Logan J Everett; Hee-Woong Lim; Kyoung-Jae Won; David J Steger; Ying Wu; Mete Civelek; Benjamin F Voight; Mitchell A Lazar
Journal:  Cell       Date:  2015-07-02       Impact factor: 41.582

Review 5.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

Review 6.  Molecular control of activation and priming in macrophages.

Authors:  Christopher K Glass; Gioacchino Natoli
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

7.  PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale.

Authors:  Martina I Lefterova; Yong Zhang; David J Steger; Michael Schupp; Jonathan Schug; Ana Cristancho; Dan Feng; David Zhuo; Christian J Stoeckert; X Shirley Liu; Mitchell A Lazar
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

8.  C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements.

Authors:  Lars Grøntved; Sam John; Songjoon Baek; Ying Liu; John R Buckley; Charles Vinson; Greti Aguilera; Gordon L Hager
Journal:  EMBO J       Date:  2013-05-10       Impact factor: 11.598

9.  Peroxisome proliferator-activated receptor γ and C/EBPα synergistically activate key metabolic adipocyte genes by assisted loading.

Authors:  Maria Stahl Madsen; Rasmus Siersbæk; Michael Boergesen; Ronni Nielsen; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

10.  Chromatin accessibility pre-determines glucocorticoid receptor binding patterns.

Authors:  Sam John; Peter J Sabo; Robert E Thurman; Myong-Hee Sung; Simon C Biddie; Thomas A Johnson; Gordon L Hager; John A Stamatoyannopoulos
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

View more
  36 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

2.  Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.

Authors:  Sheng-Mao Wu; Yee-Jee Jan; Shih-Chuan Tsai; Hung-Chuan Pan; Chin-Chang Shen; Cheng-Ning Yang; Shu-Hua Lee; Shing-Hwa Liu; Li-Wei Shen; Chien-Shan Chiu; Jack L Arbiser; Menghsiao Meng; Meei-Ling Sheu
Journal:  Cell Biol Toxicol       Date:  2022-01-01       Impact factor: 6.691

3.  Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma.

Authors:  Xiuxia Lu; Mengmeng Liu; Jing Yang; Yi Que; Xing Zhang
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

4.  Balanced control of thermogenesis by nuclear receptor corepressors in brown adipose tissue.

Authors:  Hannah J Richter; Amy K Hauck; Kirill Batmanov; Shin-Ichi Inoue; Bethany N So; Mindy Kim; Matthew J Emmett; Ronald N Cohen; Mitchell A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-08       Impact factor: 12.779

Review 5.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

6.  The Protective Role of Bmal1-Regulated Autophagy Mediated by HDAC3/SIRT1 Pathway in Myocardial Ischemia/Reperfusion Injury of Diabetic Rats.

Authors:  Zhen Qiu; Hao Ming; Yi Zhang; Yanli Yu; Shaoqing Lei; Zhong-Yuan Xia
Journal:  Cardiovasc Drugs Ther       Date:  2021-02-23       Impact factor: 3.727

7.  Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure.

Authors:  Zhongxiao Lin; Jishuo Chang; Xinzhi Li; Jianglin Wang; Xiaodan Wu; Xiaoyan Liu; YiZhun Zhu; Xi-Yong Yu
Journal:  Funct Integr Genomics       Date:  2021-12-06       Impact factor: 3.410

Review 8.  The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury.

Authors:  Li Ning; Xiong Rui; Wang Bo; Geng Qing
Journal:  Cell Death Dis       Date:  2021-07-23       Impact factor: 8.469

Review 9.  Protein acetylation: a novel modus of obesity regulation.

Authors:  Yuexia Liu; Hong Yang; Xuanchen Liu; Huihui Gu; Yizhou Li; Chao Sun
Journal:  J Mol Med (Berl)       Date:  2021-06-01       Impact factor: 4.599

10.  β-Hydroxybutyrate inhibits histone deacetylase 3 to promote claudin-5 generation and attenuate cardiac microvascular hyperpermeability in diabetes.

Authors:  Bin Li; Yijin Yu; Kun Liu; Yuping Zhang; Qi Geng; Feng Zhang; Yanning Li; Jinsheng Qi
Journal:  Diabetologia       Date:  2020-10-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.